Abstract
By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Current Pharmaceutical Design
Title:Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality
Volume: 20 Issue: 29
Author(s): Montiel-Castro, Augusto J., Baez-Yanez, Mario G. and Pacheco-Lopez Gustavo
Affiliation:
Keywords: Neuroeconomics, microbiota, probiotics, decision making process, social neurosciences.
Abstract: By focusing on the studies of primate behaviour and human neuroscience, we describe how different neurological processes are the base of proximate aspects of social-decision making. We also review the fact that distinct aspects of animal behaviour are not under conscious or abstract control and that instead they may be regulated by adaptive ´rules of thumb´. In particular, by describing the microbiota- gut-brain axis we elaborate on suggesting that microbiota has an influence on within-individual aspects of social decision making and in particular facilitating social interactions. Finally, we present comparative evidence of the role of microorganisms as modifiers of aspects of kinship, reproduction and group-members´ recognition, suggesting how microbiota also has an influence on betweenindividual aspects of decision making, which are themselves primary aspects of cooperation. In summary, we propose that modern socioeconomic choice theories may still benefit from alternative theoretical frameworks that consider the human being as a complex organism, with intrinsic constraints and capacities product of its evolutionary history, and not just as an exclusively-cognitive decision maker acting independently of its closest partners and commensals: its microbiota.
Export Options
About this article
Cite this article as:
Montiel-Castro , J. Augusto, Baez-Yanez , G. Mario and Gustavo Pacheco-Lopez, Social Neuroeconomics: The Influence of Microbiota in Partner-Choice and Sociality, Current Pharmaceutical Design 2014; 20 (29) . https://dx.doi.org/10.2174/1381612820666140130210631
DOI https://dx.doi.org/10.2174/1381612820666140130210631 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resting State Abnormalities in Psychosis Compared to Acute Cannabinoids and Opioids Challenges: A Systematic Review of Functional Imaging Studies
Current Pharmaceutical Design FMRI and Multiple Sclerosis
Current Medical Imaging Mechanisms Involved in Neuroprotective Effects of Transcranial Magnetic Stimulation
CNS & Neurological Disorders - Drug Targets Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design Zopiclone as Positive Control in Studies Examining the Residual Effects of Hypnotic Drugs on Driving Ability
Current Drug Safety Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid
Current Pharmaceutical Design Principles and Applications of Diffuse Optical Imaging for the Brain
Current Medical Imaging Functional Significance of Co-Localization of GABA and Glu in Nerve Terminals: A Hypothesis
Current Topics in Medicinal Chemistry Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?
Current Signal Transduction Therapy Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls
Current Psychiatry Reviews Enhancement of Delayed Audiovisual Response in Parkinson’s Disease: A Comparison with Normal Aged Controls
Neuroscience and Biomedical Engineering (Discontinued) Dysfunctions of the Diffusional Membrane Pathways Mediated Hemichannels in Inherited and Acquired Human Diseases
Current Vascular Pharmacology Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System
CNS & Neurological Disorders - Drug Targets Pharmacological Effect of Berberine Chloride in Propyl Thiouracil Induced Thyroidal Dysfunction - A Time Bound Study in Female Rats
Recent Patents on Drug Delivery & Formulation The Value of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Anxiety Disorders: An Integrative Review
CNS & Neurological Disorders - Drug Targets Ketamine for Chronic Pain and Treatment Resistant Depression: A Mechanistic Hypothesis
Current Drug Therapy Oligomerization of the Heptahelical G Protein Coupling Receptors: A Case for Association Using Transmembrane Helices (Supplimentry Material)
Mini-Reviews in Medicinal Chemistry Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it
Adolescent Psychiatry Proinflammatory Cytokines and Sickness Behavior in Rheumatic Diseases
Current Pharmaceutical Design Conference Proceedings: Second International Conference on Novel Psychoactive Substances (NPS) Swansea, UK; September 12-13th, 2013
Current Drug Abuse Reviews